These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16339528)

  • 1. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy.
    Spencer JS; Dockrell HM; Kim HJ; Marques MA; Williams DL; Martins MV; Martins ML; Lima MC; Sarno EN; Pereira GM; Matos H; Fonseca LS; Sampaio EP; Ottenhoff TH; Geluk A; Cho SN; Stoker NG; Cole ST; Brennan PJ; Pessolani MC
    J Immunol; 2005 Dec; 175(12):7930-8. PubMed ID: 16339528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.
    Geluk A; Spencer JS; Bobosha K; Pessolani MC; Pereira GM; Banu S; Honoré N; Reece ST; MacDonald M; Sapkota BR; Ranjit C; Franken KL; Zewdie M; Aseffa A; Hussain R; Stefani MM; Cho SN; Oskam L; Brennan PJ; Dockrell HM;
    Clin Vaccine Immunol; 2009 Mar; 16(3):352-9. PubMed ID: 19176694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.
    Dockrell HM; Brahmbhatt S; Robertson BD; Britton S; Fruth U; Gebre N; Hunegnaw M; Hussain R; Manandhar R; Murillo L; Pessolani MC; Roche P; Salgado JL; Sampaio E; Shahid F; Thole JE; Young DB
    Infect Immun; 2000 Oct; 68(10):5846-55. PubMed ID: 10992494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards an immunodiagnostic test for leprosy.
    Aráoz R; Honoré N; Banu S; Demangel C; Cissoko Y; Arama C; Uddin MK; Hadi SK; Monot M; Cho SN; Ji B; Brennan PJ; Sow S; Cole ST
    Microbes Infect; 2006 Jul; 8(8):2270-6. PubMed ID: 16797206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy.
    Launois P; DeLeys R; Niang MN; Drowart A; Andrien M; Dierckx P; Cartel JL; Sarthou JL; Van Vooren JP; Huygen K
    Infect Immun; 1994 Sep; 62(9):3679-87. PubMed ID: 7520418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.
    Geluk A; Klein MR; Franken KL; van Meijgaarden KE; Wieles B; Pereira KC; Bührer-Sékula S; Klatser PR; Brennan PJ; Spencer JS; Williams DL; Pessolani MC; Sampaio EP; Ottenhoff TH
    Infect Immun; 2005 Sep; 73(9):5636-44. PubMed ID: 16113281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
    Geluk A; van der Ploeg-van Schip JJ; van Meijgaarden KE; Commandeur S; Drijfhout JW; Benckhuijsen WE; Franken KL; Naafs B; Ottenhoff TH
    Clin Vaccine Immunol; 2010 Jun; 17(6):993-1004. PubMed ID: 20427628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
    BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
    Front Immunol; 2018; 9():2920. PubMed ID: 30631322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy.
    Martins MV; Guimarães MM; Spencer JS; Hacker MA; Costa LS; Carvalho FM; Geluk A; van der Ploeg-van Schip JJ; Pontes MA; Gonçalves HS; de Morais JP; Bandeira TJ; Pessolani MC; Brennan PJ; Pereira GM
    PLoS Negl Trop Dis; 2012; 6(4):e1616. PubMed ID: 22545169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell recognition of peptides from the Mycobacterium leprae 35 kDa protein in Thai leprosy patients, healthy contacts, and non-contacts.
    Chua-Intra B; Wattanapokayakit S; Srisungngam S; Srisungngam T; Mahotarn K; Brennan PJ; Ivanyi J
    Immunol Lett; 2003 Jul; 88(1):71-6. PubMed ID: 12853165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.
    Weir RE; Brennan PJ; Butlin CR; Dockrell HM
    Clin Exp Immunol; 1999 May; 116(2):263-9. PubMed ID: 10337017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic assays for leprosy based on T-cell epitopes.
    Dockrell HM; Brahmbhatt S; Robertson BD; Britton S; Fruth U; Gebre N; Hunegnaw M; Hussain R; Manadhar R; Murrillo L; Pessolani MC; Roche P; Salgado JL; Sampaio E; Shahid F; Thole JE; Young DB
    Lepr Rev; 2000 Dec; 71 Suppl():S55-8; discussion S58-9. PubMed ID: 11201888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.